Outpatient Neutropenic Diet Study
NCT00947648 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-06-13
Summary
The purpose of this study is to evaluate the infection rate of leukemia patients who eat two different diets. Patients in the "raw" group will eat cooked food and the addition of raw fruits and vegetables. Patients in the "cooked" group will eat only cooked foods and this is the standard neutropenic diet with no fresh fruits or vegetables allowed. The primary objective of the study is to evaluate the infection rate of leukemia patients who eat two different diets. The secondary objectives will be the incidence of fever requiring intravenous antibiotics in each group and death rate.
Conditions
Interventions
- OTHER
-
Raw Fruits & Vegetables
Diet containing fresh fruits and vegetables in addition to cooked food.
- OTHER
-
Cooked Foods
Diet containing only cooked foods.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Alison E Gardner, PhD · M.D. Anderson Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- United States
Study Locations
More Related Trials
-
PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia
NCT02996617 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
NCT04009941 ·Status: COMPLETED ·Phase: PHASE4
-
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854 ·Status: COMPLETED
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616 ·Status: COMPLETED ·Phase: PHASE2
-
Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
NCT04557709 ·Status: WITHDRAWN
-
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
NCT03968328 ·Status: COMPLETED
-
Various G-CSF Regimens to Prevent Infection During Chemotherapy
NCT00536081 ·Status: COMPLETED ·Phase: PHASE3
-
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
NCT00115206 ·Status: COMPLETED ·Phase: PHASE4
-
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01005914 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
NCT00190463 ·Status: TERMINATED ·Phase: PHASE4
-
Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC
NCT06958614 ·Status: COMPLETED
-
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
NCT00283621 ·Status: COMPLETED ·Phase: NA
-
Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma
NCT04460508 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia
NCT03449693 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer
NCT00094809 ·Status: COMPLETED ·Phase: PHASE2
-
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
NCT04101760 ·Status: UNKNOWN ·Phase: PHASE3
-
Profiling Neutrophil Counts in Patients on Chemotherapy
NCT02806557 ·Status: UNKNOWN
-
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
NCT06510868 ·Status: RECRUITING
-
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
NCT06711523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
NCT02944604 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PEG-rhG-CSF in the Prevention of Neutropenia After Chemo in Pts With Gynecological Malignancies
NCT04773327 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 ·Status: UNKNOWN
-
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
NCT01560195 ·Status: UNKNOWN ·Phase: PHASE3
-
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
NCT01484015 ·Status: COMPLETED ·Phase: PHASE1